BIO Announces 2007 BIO International Convention Official Pre Show Planner Publishing Partnership
"We are pleased to enter into this partnership with these two leading publications stated Robbi Lycett, vice president, Conventions & Conferences, BIO. "We conducted extensive attendee research after our successful BIO 2006 event in Chicago and found attendees desired more insights into the program content, trends and topics to be covered during the meeting. The addition of a Pre Show Planner, written with the editorial insights of BioExecutive and BioProcess editors, will assist our attendees in planning their show schedule and serve as a great primer for key industry trends."
The Pre Show Planner will be mailed in March to BioExecutive and BioProcess subscribers and prospective attendees identified by the 2007 BIO International Convention. The editorial content will feature five insightful chapters on Drug Discovery & Development, Upstream/Production Technologies, Downstream Procesing, Clinical Trials/Clinical Research and Manufacturing.
"We hope to provide insights into the event education sessions by highlighting the potential and the processes that are driving biotechnology breakthroughs that are turning concepts into reality, science into medicine." commented BioExecutivePublisher, Brian Caine.
The 2007 BIO International Convention will attract more than 19,000 attendees, host an exhibition of more than 1,700 companies and a Business Forum of more than 11,000 partnering meetings. The event host is the Biotechnology Industry Organization.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.
BioProcess International provides its 30,032 subscribers with the latest technologies and applications driving the development and manufacture process of biopharmaceutical applications, including: proteins, peptides, hormones, vaccines, gene therapies, cell and tissue therapies, and biodiagnostics. To learn more about BioProcess International, please visit: www.BioProcessintl.com.
BioExecutive International provides its 14,000 subscribers with an informed, authoritative, and analytical view of the business and technology challenges facing biopharmaceutical executives and business managers today, including: product development, corporate strategy, commercialization, clinical trials, strategic planning, intellectual property, and outsourcing. To learn more about BioExecutive International, please visit: www.BioExecutiveintl.com.